Swayamprakash Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Swayamprakash Patel has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Umang Shah
Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa 388421, India
11 shared publications - Ashish Patel
Department of Pharmaceutical chemistry, Parul institute of pharmacy, Parul University, Vadodara-391760, Gujarat, India
10 shared publications - Mehul Patel
Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT-Campus
10 shared publications - Nilay Solanki
Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa-388421, India
10 shared publications Mehul Patel
Department of Pharmaceutical Chemistry, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa 388421, India
8 shared publicationsJagruti Desai
Department of Pharmaceutics and Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa, 388421, India
6 shared publications
Latest Publications
- 5 February 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21  (2) , 168
Exploring Potential of Topical Acitretin Transferosomal Formulation for Management of Psoriasis: In vitro and In vivo Analysis
- 5 February 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21  (2) , 168
Exploring Potential of Topical Acitretin Transferosomal Formulation for Management of Psoriasis: In vitro and In vivo Analysis
- 5 September 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20  (5) , 1-26
Advancing Lamotrigine Therapy: Piezoelectric Atomized Cloud Drying-Developed Microparticles in Lyophilized Orally Disintegrating Tablets with Characterization and PBPK Simulation for Enhanced Dissolution, Rapid Absorption, and Faster Onset of Action
- 5 September 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20  (5) , 1-26
Advancing Lamotrigine Therapy: Piezoelectric Atomized Cloud Drying-Developed Microparticles in Lyophilized Orally Disintegrating Tablets with Characterization and PBPK Simulation for Enhanced Dissolution, Rapid Absorption, and Faster Onset of Action
- 6 August 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21
Harnessing the Power of Ferulic Acid: A Comprehensive Review of its Therapeutic Mechanisms, Delivery Innovations, and Clinical Impact
Ferulic acid, a natural phenolic compound widely distributed in various plant sources, has emerged as a bioactive molecule with significant pharmaceutical potential. Its therapeutic benefits include potent antioxidant, anti-inflammatory, and anti-aging properties, which make it a valuable candidate in pharmaceuticals, nutraceuticals, and cosmetics. Despite its diverse applications, the bioavailability of ferulic acid remains a challenge, necessitating the development of innovative delivery systems to optimize its therapeutic efficacy. This review provides a detailed exploration of advanced delivery systems, including nanotechnology-based carriers, prodrugs, and other innovative approaches to overcome these limitations. A distinctive highlight of this review is the integration of ferulic acid with probiotics, a novel trend that enhances gut health, modulates the immune system, and regulates metabolic pathways, leading to multifaceted therapeutic outcomes. Additionally, the review discusses the therapeutic applications of ferulic acid, including its roles as an antioxidant, anti-inflammatory agent, and precursor to vanillin. Its significance in cosmetics, particularly as a skin-whitening and photoprotective agent, is also analyzed. Moreover, the review provides an overview of patents, clinical trials, and ongoing research, underscoring the compound's wide-ranging therapeutic scope. The discussion spans its metabolism, therapeutic mechanisms, and its use as a food additive for preventing discoloration and promoting growth. By synthesizing recent advancements and trends, this review serves as a comprehensive resource, offering insights into the pharmacological and therapeutic landscape of ferulic acid and guiding future research and development efforts within the scientific and industrial communities.
- 6 August 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21
Harnessing the Power of Ferulic Acid: A Comprehensive Review of its Therapeutic Mechanisms, Delivery Innovations, and Clinical Impact
Ferulic acid, a natural phenolic compound widely distributed in various plant sources, has emerged as a bioactive molecule with significant pharmaceutical potential. Its therapeutic benefits include potent antioxidant, anti-inflammatory, and anti-aging properties, which make it a valuable candidate in pharmaceuticals, nutraceuticals, and cosmetics. Despite its diverse applications, the bioavailability of ferulic acid remains a challenge, necessitating the development of innovative delivery systems to optimize its therapeutic efficacy. This review provides a detailed exploration of advanced delivery systems, including nanotechnology-based carriers, prodrugs, and other innovative approaches to overcome these limitations. A distinctive highlight of this review is the integration of ferulic acid with probiotics, a novel trend that enhances gut health, modulates the immune system, and regulates metabolic pathways, leading to multifaceted therapeutic outcomes. Additionally, the review discusses the therapeutic applications of ferulic acid, including its roles as an antioxidant, anti-inflammatory agent, and precursor to vanillin. Its significance in cosmetics, particularly as a skin-whitening and photoprotective agent, is also analyzed. Moreover, the review provides an overview of patents, clinical trials, and ongoing research, underscoring the compound's wide-ranging therapeutic scope. The discussion spans its metabolism, therapeutic mechanisms, and its use as a food additive for preventing discoloration and promoting growth. By synthesizing recent advancements and trends, this review serves as a comprehensive resource, offering insights into the pharmacological and therapeutic landscape of ferulic acid and guiding future research and development efforts within the scientific and industrial communities.
- 11 July 2025
- Published by Pharmaceutical and Healthcare Sciences Society (PHSS) in EJPPS EUROPEAN JOURNAL OF PARENTERAL AND PHARMACEUTICAL SCIENCES
Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future; A Case Study of Current Practice and Future Developments
The oral route of giving medicine is a well-liked, practical, and generally approved way of drug delivery. With the introduction of pre-compression, the ultra-high-speed press, and induced die feeding during the last several decades, the formulation of solid oral dosage forms has improved. The federal regulations and concepts pertaining to bioavailability, bioequivalence, and validation have had an influence on tablet formulation, design, and production. In today's world, there are numerous divisions involved in manufacturing tablet dosage forms, which include the material store, dispensing area, slagging, granulation and lubrication, bin charging, compression, and coating, work in process (a general term for partially finished goods), inspection rooms, primary and secondary packaging areas, documentation cell, human resource area, and quality assurance, microchemical labs, quality control labs, laboratories for validation, stability testing, and many more. In the future, industrial facilities will rely heavily on machines like AGVs, AI robots, hydraulic arms, and other automated equipment that are programmed to perform tasks with very high-quality standards. Although some human involvement will still be needed for checking and verifying processes, most of the work will be carried out by these machines, reducing the need for a large number of human workers to complete the manufacturing process of tableting. Keywords: Tablet Manufacturing plant, Quality Assurance, Production, Automation, Pharmaceutical industry.
- 11 July 2025
- Published by Pharmaceutical and Healthcare Sciences Society (PHSS) in EJPPS EUROPEAN JOURNAL OF PARENTERAL AND PHARMACEUTICAL SCIENCES
Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future; A Case Study of Current Practice and Future Developments
The oral route of giving medicine is a well-liked, practical, and generally approved way of drug delivery. With the introduction of pre-compression, the ultra-high-speed press, and induced die feeding during the last several decades, the formulation of solid oral dosage forms has improved. The federal regulations and concepts pertaining to bioavailability, bioequivalence, and validation have had an influence on tablet formulation, design, and production. In today's world, there are numerous divisions involved in manufacturing tablet dosage forms, which include the material store, dispensing area, slagging, granulation and lubrication, bin charging, compression, and coating, work in process (a general term for partially finished goods), inspection rooms, primary and secondary packaging areas, documentation cell, human resource area, and quality assurance, microchemical labs, quality control labs, laboratories for validation, stability testing, and many more. In the future, industrial facilities will rely heavily on machines like AGVs, AI robots, hydraulic arms, and other automated equipment that are programmed to perform tasks with very high-quality standards. Although some human involvement will still be needed for checking and verifying processes, most of the work will be carried out by these machines, reducing the need for a large number of human workers to complete the manufacturing process of tableting. Keywords: Tablet Manufacturing plant, Quality Assurance, Production, Automation, Pharmaceutical industry.
- 3 February 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26  (2) , 1-13
Machine Learning-Based Prediction of Drug Solubility in Lipidic Environments: The Sol_ME Tool for Optimizing Lipid-Based Formulations with a Preliminary Apalutamide Case Study
Lipid-based formulations are essential for enhancing drug solubility and bioavailability, yet selecting optimal lipid excipients for specific drugs remains
- 3 February 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26  (2) , 1-13
Machine Learning-Based Prediction of Drug Solubility in Lipidic Environments: The Sol_ME Tool for Optimizing Lipid-Based Formulations with a Preliminary Apalutamide Case Study
Lipid-based formulations are essential for enhancing drug solubility and bioavailability, yet selecting optimal lipid excipients for specific drugs remains
- 8 December 2024
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 50  (12) , 995-1007
Optimizing critical quality attributes of fast disintegrating tablets using artificial neural networks: a scientific benchmark study
Objective: The objective of this study is to create predictive models utilizing machine learning algorithms, including Artificial Neural Networks (ANN), k-nearest neighbor (kNN), support vector machines (SVM), and linear regression, to predict critical quality attributes (CQAs) such as hardness, friability, and disintegration time of fast disintegrating tablets (FDTs). Methods: A dataset of 864 batches of FDTs was generated by varying binder types and amounts, disintegrants, diluents, punch sizes, and compression forces. Preprocessing steps included normalizing numerical features based on industry standards, one-hot encoding for categorical variables, and addressing outliers to ensure data consistency. Four machine learning models were trained and evaluated on R2 values and mean squared error (MSE). Feature importance was analyzed using permutation importance, and statistical validation (p < 0.05) and confidence intervals were computed for model performance. The 'differential_evolution' function was used to optimize the formulation. Results: Among the models, ANN demonstrated the highest predictive accuracy, achieving R-2 values up to 0.9550 with the lowest MSE across training and test datasets, outperforming kNN, SVM, and linear regression. The ANN's ability to model complex, non-linear interactions between formulation variables was statistically significant, as validated through six checkpoint batches of acetylsalicylic acid FDTs. The feature importance analysis revealed compression force, binder type, and punch size as the most influential factors affecting hardness, while disintegrant type influenced friability. The 'differential_evolution' function effectively optimized the CQAs, resulting in FDTs with ideal characteristics. Conclusion: The ANN model, integrated with differential evolution, provided a robust tool for optimizing FDT formulations by accurately predicting CQAs and reducing the need for extensive experimental trials. Compared to traditional optimization methods, ANN excels in capturing intricate multi-variable relationships, making it a valuable approach for scaling beyond acetylsalicylic acid to other formulations. This method enhances the consistency and efficiency of tablet formulation, supporting broader pharmaceutical applications
- 8 December 2024
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 50  (12) , 995-1007
Optimizing critical quality attributes of fast disintegrating tablets using artificial neural networks: a scientific benchmark study
Objective: The objective of this study is to create predictive models utilizing machine learning algorithms, including Artificial Neural Networks (ANN), k-nearest neighbor (kNN), support vector machines (SVM), and linear regression, to predict critical quality attributes (CQAs) such as hardness, friability, and disintegration time of fast disintegrating tablets (FDTs). Methods: A dataset of 864 batches of FDTs was generated by varying binder types and amounts, disintegrants, diluents, punch sizes, and compression forces. Preprocessing steps included normalizing numerical features based on industry standards, one-hot encoding for categorical variables, and addressing outliers to ensure data consistency. Four machine learning models were trained and evaluated on R2 values and mean squared error (MSE). Feature importance was analyzed using permutation importance, and statistical validation (p < 0.05) and confidence intervals were computed for model performance. The 'differential_evolution' function was used to optimize the formulation. Results: Among the models, ANN demonstrated the highest predictive accuracy, achieving R-2 values up to 0.9550 with the lowest MSE across training and test datasets, outperforming kNN, SVM, and linear regression. The ANN's ability to model complex, non-linear interactions between formulation variables was statistically significant, as validated through six checkpoint batches of acetylsalicylic acid FDTs. The feature importance analysis revealed compression force, binder type, and punch size as the most influential factors affecting hardness, while disintegrant type influenced friability. The 'differential_evolution' function effectively optimized the CQAs, resulting in FDTs with ideal characteristics. Conclusion: The ANN model, integrated with differential evolution, provided a robust tool for optimizing FDT formulations by accurately predicting CQAs and reducing the need for extensive experimental trials. Compared to traditional optimization methods, ANN excels in capturing intricate multi-variable relationships, making it a valuable approach for scaling beyond acetylsalicylic acid to other formulations. This method enhances the consistency and efficiency of tablet formulation, supporting broader pharmaceutical applications